➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Harvard Business School
McKinsey
Medtronic
Boehringer Ingelheim

Last Updated: January 21, 2021

DrugPatentWatch Database Preview

Repaglinide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Prices for repaglinide

See drug prices for repaglinide

Recent Clinical Trials for repaglinide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Dasman Diabetes InstitutePhase 4
Ministry of Health, KuwaitPhase 4
Texas Diabetes InstitutePhase 4

See all repaglinide clinical trials

Paragraph IV (Patent) Challenges for REPAGLINIDE
Tradename Dosage Ingredient NDA Submissiondate
PRANDIN TABLET;ORAL repaglinide 020741 2005-02-10

US Patents and Regulatory Information for repaglinide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Labs Llc REPAGLINIDE repaglinide TABLET;ORAL 201189-001 Jul 17, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Boscogen REPAGLINIDE repaglinide TABLET;ORAL 091517-003 Apr 24, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Inc REPAGLINIDE repaglinide TABLET;ORAL 077571-002 Jul 11, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for repaglinide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-001 Dec 22, 1997   Start Trial   Start Trial
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-002 Dec 22, 1997   Start Trial   Start Trial
Gemini Labs Llc PRANDIN repaglinide TABLET;ORAL 020741-003 Dec 22, 1997   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Medtronic
McKesson
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.